Anti-Obesity Prescription Drugs Market Report

Global and Regional Anti-Obesity Prescription Drugs Market Details Research Report 2021-2026

  • POSTDATE：Jun 30, 2021
  • PAGES：178
  • REPORT CODE：GMM753343
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Global Anti-Obesity Prescription Drugs Market Report provides evaluation of the market development from historical studies. This report further provides forecasts by performing comprehensive market analysis.  It covers thorough market analysis for the forecasted period 2021-2026. Moreover, this market study focuses on market classification into different segments along with thorough analysis of the competitors, key players and their profiles. The market size is calculated on the basis of revenue generated and volume.  Knowing dynamics of the market plays an important role and this report sheds light on dynamics like drivers and restraints.

    Such comprehensive Anti-Obesity Prescription Drugs market report further covers factors that influence market along with potent developing factors for various End-users, Types and Regions to outline the most capturing development trends of the Hydraulic Work Supports Industry. In addition, it focuses on some prominent investment sectors in regions such as Latin America, Europe, Asia Pacific, Africa and Middle East. This unique market report presents precious opinion of strategic adjustments for new key entrant as well present groups. In this research analysis, market capacity and consumption potential of prominent players are mentioned.

    In 2020, COVID-19 has had a certain impact on the global economy, so the report considers the impact of COVID-19 on the Global Anti-Obesity Prescription Drugs market.

    By Player:

    • Vivus

    • Orexigen Therapeutics

    • Arena Pharmaceuticals

    • F Hoffmann La Roche Ltd

    • Alizyme

    • Boehringer Ingelheim

    • Glaxosmithkline

    • Novo Nordisk A/s

    By Type:

    • Orlistat

    • Phentermine and Topiramate

    • Bupropion and Naltrexone

    • Lorcaserin

    • Liraglutide

    By End-User:

    • Pediatric

    • Adult

    By Geography:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • United Kingdom

    • France

    • Italy

    • Russia

    • Spain

    • Netherlands

    • Switzerland

    • Turkey

    • Poland

    • Sweden

    • Belgium

    • Austria

    • Others

    Asia

    • China

    • Japan

    • India

    • South Korea

    • Indonesia

    • Thailand

    • Malaysia

    • Singapore

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Argentina

    • Colombia

    • Chile

    • Others

    Middle East

    • United Arab Emirates (UAE)

    • Saudi Arabia

    • Others

    Africa

    • Nigeria

    • Egypt

    • South Africa

    • Others

    Oceania

    • Australia

    • New Zealand

    • Others


    Major Reasons to Buy this Report

    This market report is the perfect presentation of the qualitative and quantitative analysis of the market according to categorization considering economic and non-economic factors.

    • It also provides provision of market value (USD Million) data for every segment and sub-segment.

    • This report further focuses on prominent regions and segmentation of the market, which is anticipated to record the rapid growth and dominate the market.

    • Market analysis is done on the basis of major regions covering consumption of the product in particular region and factors affecting the market growth in every region.

    • This market report further sheds light on competitive landscape, which indicates the place of the prominent key players in the market. It also covers a few crucial market strategies followed by the major players of the market such as partnerships, new service launches, business expansions and acquisitions of the companies profiled during last five years.

    • This market study sheds light on a wide range of company profiles, which contain company insights, SWOT analysis for the prominent industry players, company overview and product benchmarking.

    • The present and future market outlook of the industry is also mentioned in this unique market report along with recent development such as drivers, opportunities, challenges and market restricting factors of developed and rising regions.  

    • This market report is the unique depiction of porter’s five forces analysis, which is performed thorough analysis of the market perspectives.  Insights into market scenario is provided through value chain

    •  It further focuses on growth opportunities of upcoming years and depicts market scenario along with market dynamics.

    • This market report also provides six month post-sales analyst support.


    Customization of the Report

    Please feel free to contact our sales team in case of any Query or Customization Requirements. Our expert team will give you right solutions for your query.

  • TABLE OF CONTENT

    1 Anti-Obesity Prescription Drugs Market Overview

    • 1.1 Product Definition and Study Scope

      • 1.1.1 Study Scope by Types

      • 1.1.2 Study Scope by Application

    • 1.2 Market Overview and Trends

      • 1.2.1 Global Anti-Obesity Prescription Drugs Market Size and Growth Rate from 2016 to 2026

      • 1.2.2 Market Overview (Current Market Status)

      • 1.2.3 Qualitative Analysis of Market Trends

    • 1.3 Business Environment Analysis Tools

      • 1.3.1 PESTEL Analysis

      • 1.3.2 Porter's Five Forces Analysis

      • 1.3.3 Major Deals & Strategic Alliances Analysis

    2 Major Players Market Position

    • 2.1 Global Anti-Obesity Prescription Drugs Production Capacity and Market Share by Manufacturers (2016-2021)

    • 2.2 Global Anti-Obesity Prescription Drugs Market Revenue and Market Share by Manufacturers (2016-2021)

    • 2.3 Global Anti-Obesity Prescription Drugs Market Revenue and Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

    • 2.4 Manufacturers Anti-Obesity Prescription Drugs Plant Distribution and Sales Country

    3 Key Competitor and Financial Performance

    • 3.1 Vivus

      • 3.1.1 Vivus - Company Business Overview

      • 3.1.2 Vivus - Company Financial Performance

      • 3.1.3 Vivus - Company Financial Performance of Anti-Obesity Prescription Drugs

      • 3.1.4 Anti-Obesity Prescription Drugs Product Benchmarking

      • 3.1.5 Strategic Initiatives

    • 3.2 Orexigen Therapeutics

      • 3.2.1 Orexigen Therapeutics - Company Business Overview

      • 3.2.2 Orexigen Therapeutics - Company Financial Performance

      • 3.2.3 Orexigen Therapeutics - Company Financial Performance of Anti-Obesity Prescription Drugs

      • 3.2.4 Anti-Obesity Prescription Drugs Product Benchmarking

      • 3.2.5 Strategic Initiatives

    • 3.3 Arena Pharmaceuticals

      • 3.3.1 Arena Pharmaceuticals - Company Business Overview

      • 3.3.2 Arena Pharmaceuticals - Company Financial Performance

      • 3.3.3 Arena Pharmaceuticals - Company Financial Performance of Anti-Obesity Prescription Drugs

      • 3.3.4 Anti-Obesity Prescription Drugs Product Benchmarking

      • 3.3.5 Strategic Initiatives

    • 3.4 F Hoffmann La Roche Ltd

      • 3.4.1 F Hoffmann La Roche Ltd - Company Business Overview

      • 3.4.2 F Hoffmann La Roche Ltd - Company Financial Performance

      • 3.4.3 F Hoffmann La Roche Ltd - Company Financial Performance of Anti-Obesity Prescription Drugs

      • 3.4.4 Anti-Obesity Prescription Drugs Product Benchmarking

      • 3.4.5 Strategic Initiatives

    • 3.5 Alizyme

      • 3.5.1 Alizyme - Company Business Overview

      • 3.5.2 Alizyme - Company Financial Performance

      • 3.5.3 Alizyme - Company Financial Performance of Anti-Obesity Prescription Drugs

      • 3.5.4 Anti-Obesity Prescription Drugs Product Benchmarking

      • 3.5.5 Strategic Initiatives

    • 3.6 Boehringer Ingelheim

      • 3.6.1 Boehringer Ingelheim - Company Business Overview

      • 3.6.2 Boehringer Ingelheim - Company Financial Performance

      • 3.6.3 Boehringer Ingelheim - Company Financial Performance of Anti-Obesity Prescription Drugs

      • 3.6.4 Anti-Obesity Prescription Drugs Product Benchmarking

      • 3.6.5 Strategic Initiatives

    • 3.7 Glaxosmithkline

      • 3.7.1 Glaxosmithkline - Company Business Overview

      • 3.7.2 Glaxosmithkline - Company Financial Performance

      • 3.7.3 Glaxosmithkline - Company Financial Performance of Anti-Obesity Prescription Drugs

      • 3.7.4 Anti-Obesity Prescription Drugs Product Benchmarking

      • 3.7.5 Strategic Initiatives

    • 3.8 Novo Nordisk A/s

      • 3.8.1 Novo Nordisk A/s - Company Business Overview

      • 3.8.2 Novo Nordisk A/s - Company Financial Performance

      • 3.8.3 Novo Nordisk A/s - Company Financial Performance of Anti-Obesity Prescription Drugs

      • 3.8.4 Anti-Obesity Prescription Drugs Product Benchmarking

      • 3.8.5 Strategic Initiatives

    4 Global Anti-Obesity Prescription Drugs Market Segment Analysis (Types Level)

    • 4.1 Purchasing Strategy based on Purchasing Positioning Model

    • 4.2 Global Anti-Obesity Prescription Drugs Market Revenue and Market Share by Types (Historical)

      • 4.2.1 Global Revenue and Growth Rate of Orlistat 2016-2021

      • 4.2.2 Global Revenue and Growth Rate of Phentermine and Topiramate 2016-2021

      • 4.2.3 Global Revenue and Growth Rate of Bupropion and Naltrexone 2016-2021

      • 4.2.4 Global Revenue and Growth Rate of Lorcaserin 2016-2021

      • 4.2.5 Global Revenue and Growth Rate of Liraglutide 2016-2021

    • 4.3 Global Anti-Obesity Prescription Drugs Market Sales and Market Share by Types (Historical)

      • 4.3.1 Global Sales and Growth Rate of Orlistat 2016-2021

      • 4.3.2 Global Sales and Growth Rate of Phentermine and Topiramate 2016-2021

      • 4.3.3 Global Sales and Growth Rate of Bupropion and Naltrexone 2016-2021

      • 4.3.4 Global Sales and Growth Rate of Lorcaserin 2016-2021

      • 4.3.5 Global Sales and Growth Rate of Liraglutide 2016-2021

    • 4.4 Global Anti-Obesity Prescription Drugs Market Revenue and Market Share by Types (Forecast)

    • 4.5 Global Anti-Obesity Prescription Drugs Market Sales and Market Share by Types (Forecast)

    • 4.6 Global Anti-Obesity Prescription Drugs Market Price By Type from 2016 to 2026

    5 Global Anti-Obesity Prescription Drugs Market Segment Analysis (Application Level)

    • 5.1 Downstream Industry Demand Analysis of Anti-Obesity Prescription Drugs

    • 5.2 Global Anti-Obesity Prescription Drugs Market Revenue and Market Share by Application (Historical)

      • 5.2.1 Global Revenue and Growth Rate of Pediatric 2016-2021

      • 5.2.2 Global Revenue and Growth Rate of Adult 2016-2021

    • 5.3 Global Anti-Obesity Prescription Drugs Market Sales and Market Share by Application (Historical)

      • 5.3.1 Global Sales and Growth Rate of Pediatric 2016-2021

      • 5.3.2 Global Sales and Growth Rate of Adult 2016-2021

    • 5.4 Global Anti-Obesity Prescription Drugs Market Revenue and Market Share by Application (Forecast)

    • 5.5 Global Anti-Obesity Prescription Drugs Market Sales and Market Share by Application (Forecast)

    6 Global Anti-Obesity Prescription Drugs Market Segment Analysis (Geography Level)

    • 6.1 Global Anti-Obesity Prescription Drugs Market Revenue and Market Share by Geography (Historical)

    • 6.2 Global Anti-Obesity Prescription Drugs Market Sales and Market Share by Geography (Historical)

    • 6.3 Global Anti-Obesity Prescription Drugs Market Revenue and Market Share by Geography (Forecast)

    • 6.4 Global Anti-Obesity Prescription Drugs Market Sales and Market Share by Geography (Forecast)

    • 6.5 Top Sales Country Advantage Analysis

    • 6.6 Top 5 Export Countries in Anti-Obesity Prescription Drugs Market from 2016 to 2020

    • 6.7 Top 5 Import Countries in Anti-Obesity Prescription Drugs Market from 2016 to 2020

    7. North America Anti-Obesity Prescription Drugs Market Segment Analysis and Investment Attractiveness

    • 7.1 North America Anti-Obesity Prescription Drugs Market Segment by Countries

      • 7.1.1 North America Anti-Obesity Prescription Drugs Market Revenue Segment by Countries

      • 7.1.2 North America Anti-Obesity Prescription Drugs Market Sales Segment by Countries

      • 7.1.3 USA

      • 7.1.4 Canada

      • 7.1.5 Mexico

    • 7.2 North America Anti-Obesity Prescription Drugs Market Segment (Product Type Level)

    • 7.3 North America Anti-Obesity Prescription Drugs Market Segment (Application/Industry Level)

    • 7.4 Key Country Economy in North America

    • 7.5 Analysis of Investment Attractiveness of Major Countries

    8 Europe Anti-Obesity Prescription Drugs Market Segment Analysis and Investment Attractiveness

    • 8.1 Europe Anti-Obesity Prescription Drugs Market Segment by Countries

      • 8.1.1 Europe Anti-Obesity Prescription Drugs Market Revenue Segment by Countries

      • 8.1.2 Europe Anti-Obesity Prescription Drugs Market Sales Segment by Countries

      • 8.1.3 Germany

      • 8.1.4 United Kingdom

      • 8.1.5 France

      • 8.1.6 Italy

      • 8.1.7 Russia

      • 8.1.8 Spain

      • 8.1.9 Netherlands

      • 8.1.10 Switzerland

      • 8.1.11 Turkey

      • 8.1.12 Poland

      • 8.1.13 Sweden

      • 8.1.14 Belgium

      • 8.1.15 Austria

      • 8.1.16 Others

    • 8.2 Europe Anti-Obesity Prescription Drugs Market Segment (Product Type Level)

    • 8.3 Europe Anti-Obesity Prescription Drugs Market Segment (Application/Industry Level)

    • 8.4 Key Country Economy in Europe

    • 8.5 Analysis of Investment Attractiveness of Major Countries

    9 Asia Anti-Obesity Prescription Drugs Market Segment Analysis and Investment Attractiveness

    • 9.1 Asia Anti-Obesity Prescription Drugs Market Segment by Countries

      • 9.1.1 Asia Anti-Obesity Prescription Drugs Market Revenue Segment by Countries

      • 9.1.2 Asia Anti-Obesity Prescription Drugs Market Sales Segment by Countries

      • 9.1.3 China

      • 9.1.4 Japan

      • 9.1.5 India

      • 9.1.6 South Korea

      • 9.1.7 Malaysia

      • 9.1.8 Vietnam

      • 9.1.9 Philippines

      • 9.1.10 Singapore

      • 9.1.11 Thailand

      • 9.1.12 Others

    • 9.2 Asia Anti-Obesity Prescription Drugs Market Segment (Product Type Level)

    • 9.3 Asia Anti-Obesity Prescription Drugs Market Segment (Application/Industry Level)

    • 9.4 Key Country Economy in Asia Pacific

    • 9.5 Analysis of Investment Attractiveness of Major Countries

    10 South America Anti-Obesity Prescription Drugs Market Segment Analysis and Investment Attractiveness

    • 10.1 South America Anti-Obesity Prescription Drugs Market Segment by Countries

      • 10.1.1 South America Anti-Obesity Prescription Drugs Market Revenue Segment by Countries

      • 10.1.2 South America Anti-Obesity Prescription Drugs Market Sales Segment by Countries

      • 10.1.3 Brazil

      • 10.1.4 Argentina

      • 10.1.5 Colombia

      • 10.1.6 Chile

      • 10.1.7 Others

    • 10.2 South America Anti-Obesity Prescription Drugs Market Segment (Product Type Level)

    • 10.3 South America Anti-Obesity Prescription Drugs Market Segment (Application/Industry Level)

    • 10.4 Key Country Economy in Asia Pacific

    • 10.5 Analysis of Investment Attractiveness of Major Countries

    11 Middle East Anti-Obesity Prescription Drugs Market Segment Analysis and Investment Attractiveness

    • 11.1 Middle East Anti-Obesity Prescription Drugs Market Segment by Countries

      • 11.1.1 Middle East Anti-Obesity Prescription Drugs Market Revenue Segment by Countries

      • 11.1.2 Middle East Anti-Obesity Prescription Drugs Market Sales Segment by Countries

      • 11.1.3 United Arab Emirates (UAE)

      • 11.1.4 Saudi Arabia

      • 11.1.5 Others

    • 11.2 Middle East Anti-Obesity Prescription Drugs Market Segment (Product Type Level)

    • 11.3 Middle East Anti-Obesity Prescription Drugs Market Segment (Application/Industry Level)

    • 11.4 Key Country Economy in Middle East

    • 11.5 Analysis of Investment Attractiveness of Major Countries

    12 Africa Anti-Obesity Prescription Drugs Market Segment Analysis and Investment Attractiveness

    • 12.1 Africa Anti-Obesity Prescription Drugs Market Segment by Countries

      • 12.1.1 Africa Anti-Obesity Prescription Drugs Market Revenue Segment by Countries

      • 12.1.2 Africa Anti-Obesity Prescription Drugs Market Sales Segment by Countries

      • 12.1.3 Nigeria

      • 12.1.4 Egypt

      • 12.1.5 South Africa

      • 12.1.6 Others

    • 12.2 Africa Anti-Obesity Prescription Drugs Market Segment (Product Type Level)

    • 12.3 Africa Anti-Obesity Prescription Drugs Market Segment (Application/Industry Level)

    • 12.4 Key Country Economy in Africa

    • 12.5 Analysis of Investment Attractiveness of Major Countries

    13 Oceania Anti-Obesity Prescription Drugs Market Segment Analysis and Investment Attractiveness

    • 13.1 Oceania Anti-Obesity Prescription Drugs Market Segment by Countries

      • 13.1.1 Oceania Anti-Obesity Prescription Drugs Market Revenue Segment by Countries

      • 13.1.2 Oceania Anti-Obesity Prescription Drugs Market Sales Segment by Countries

      • 13.1.3 Australia

      • 13.1.4 New Zealand

      • 13.1.5 Others

    • 13.2 Oceania Anti-Obesity Prescription Drugs Market Segment (Product Type Level)

    • 13.3 Oceania Anti-Obesity Prescription Drugs Market Segment (Application/Industry Level)

    • 13.4 Key Country Economy in Oceania

    • 13.5 Analysis of Investment Attractiveness of Major Countries

    14 Supply Chain Analysis

    • 14.1 Upstream Market Analysis

      • 14.1.1 Key Raw Materials Production Base and Market Concentration Rate

      • 14.1.2 Key Raw Materials Price Trend

    • 14.2 Anti-Obesity Prescription Drugs Production Analysis

      • 14.2.1 Manufacturing Cost Structure of Anti-Obesity Prescription Drugs

      • 14.2.2 Manufacturing Process Analysis of Anti-Obesity Prescription Drugs

      • 14.2.3 Source of Technology

      • 14.2.4 Competitive Landscape

    • 14.3 Downstream Market Analysis

      • 14.3.1 Customer Positioning Analysis

      • 14.3.2 Major Downstream Buyers of Anti-Obesity Prescription Drugs Analysis

    15 Market Influences Factors Analysis

    • 15.1 Changes from the Related Industries

    • 15.2 Substitutes Threat

    • 15.3 Customer Preference Change

    • 15.4 Upstream and Downstream Fluctuation

    • 15.5 COVID-19 Impact

      • 15.5.1 COVID-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

      • 15.5.2 Anti-Obesity Prescription Drugs Industry Market Status, Pre-COVID-19

      • 15.5.3 Anti-Obesity Prescription Drugs Industry Market Status, Post-COVID-19

      • 15.5.4 Impact of COVID-19 on Supply Chain

    • 15.6 Post-COVID-19 Anti-Obesity Prescription Drugs Industry Opportunity

    16 Key Research Findings


    The List of Tables and Figures

    • Figure Anti-Obesity Prescription Drugs Product Picture

    • Table Anti-Obesity Prescription Drugs Product Definition

    • Table Study Scope by Types

    • Figure Global Anti-Obesity Prescription Drugs Market Value by Type (2016 - 2026)

    • Table Study Scope by Application

    • Figure Global Anti-Obesity Prescription Drugs Market Value by Application (2016 - 2026)

    • Figure Global Anti-Obesity Prescription Drugs Market Size and Growth Rate from 2016 to 2026

    • Table Global Anti-Obesity Prescription Drugs Production Capacity by Manufacturers (2016-2021)

    • Table Global Anti-Obesity Prescription Drugs Production Capacity Market Share by Manufacturers (2016-2021)

    • Table Global Anti-Obesity Prescription Drugs Revenue by Manufacturers (2016-2021)

    • Table Global Anti-Obesity Prescription Drugs Revenue Market Share by Manufacturers (2016-2021)

    • Table Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

    • Table Manufacturers Anti-Obesity Prescription Drugs Plant Distribution and Sales Country

    • Table Vivus - Company Business Overview

    • Figure Vivus Total Revenue from 2018 to 2020

    • Table Vivus Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Vivus Sales and Growth Rate Analysis of Anti-Obesity Prescription Drugs

    • Figure Revenue and Market Share Analysis of Vivus

    • Table Anti-Obesity Prescription Drugs Product Benchmarking

    • Table Orexigen Therapeutics - Company Business Overview

    • Figure Orexigen Therapeutics Total Revenue from 2018 to 2020

    • Table Orexigen Therapeutics Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Orexigen Therapeutics Sales and Growth Rate Analysis of Anti-Obesity Prescription Drugs

    • Figure Revenue and Market Share Analysis of Orexigen Therapeutics

    • Table Anti-Obesity Prescription Drugs Product Benchmarking

    • Table Arena Pharmaceuticals - Company Business Overview

    • Figure Arena Pharmaceuticals Total Revenue from 2018 to 2020

    • Table Arena Pharmaceuticals Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Arena Pharmaceuticals Sales and Growth Rate Analysis of Anti-Obesity Prescription Drugs

    • Figure Revenue and Market Share Analysis of Arena Pharmaceuticals

    • Table Anti-Obesity Prescription Drugs Product Benchmarking

    • Table F Hoffmann La Roche Ltd - Company Business Overview

    • Figure F Hoffmann La Roche Ltd Total Revenue from 2018 to 2020

    • Table F Hoffmann La Roche Ltd Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure F Hoffmann La Roche Ltd Sales and Growth Rate Analysis of Anti-Obesity Prescription Drugs

    • Figure Revenue and Market Share Analysis of F Hoffmann La Roche Ltd

    • Table Anti-Obesity Prescription Drugs Product Benchmarking

    • Table Alizyme - Company Business Overview

    • Figure Alizyme Total Revenue from 2018 to 2020

    • Table Alizyme Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Alizyme Sales and Growth Rate Analysis of Anti-Obesity Prescription Drugs

    • Figure Revenue and Market Share Analysis of Alizyme

    • Table Anti-Obesity Prescription Drugs Product Benchmarking

    • Table Boehringer Ingelheim - Company Business Overview

    • Figure Boehringer Ingelheim Total Revenue from 2018 to 2020

    • Table Boehringer Ingelheim Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Boehringer Ingelheim Sales and Growth Rate Analysis of Anti-Obesity Prescription Drugs

    • Figure Revenue and Market Share Analysis of Boehringer Ingelheim

    • Table Anti-Obesity Prescription Drugs Product Benchmarking

    • Table Glaxosmithkline - Company Business Overview

    • Figure Glaxosmithkline Total Revenue from 2018 to 2020

    • Table Glaxosmithkline Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Glaxosmithkline Sales and Growth Rate Analysis of Anti-Obesity Prescription Drugs

    • Figure Revenue and Market Share Analysis of Glaxosmithkline

    • Table Anti-Obesity Prescription Drugs Product Benchmarking

    • Table Novo Nordisk A/s - Company Business Overview

    • Figure Novo Nordisk A/s Total Revenue from 2018 to 2020

    • Table Novo Nordisk A/s Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Novo Nordisk A/s Sales and Growth Rate Analysis of Anti-Obesity Prescription Drugs

    • Figure Revenue and Market Share Analysis of Novo Nordisk A/s

    • Table Anti-Obesity Prescription Drugs Product Benchmarking

    • Table Purchasing Strategy based on Purchasing Positioning Model

    • Table Global Anti-Obesity Prescription Drugs Market Revenue by Types (Historical)

    • Table Global Anti-Obesity Prescription Drugs Market Revenue Market Share by Types (Historical)

    • Figure Global Revenue and Growth Rate of Orlistat 2016-2021

    • Figure Global Revenue and Growth Rate of Phentermine and Topiramate 2016-2021

    • Figure Global Revenue and Growth Rate of Bupropion and Naltrexone 2016-2021

    • Figure Global Revenue and Growth Rate of Lorcaserin 2016-2021

    • Figure Global Revenue and Growth Rate of Liraglutide 2016-2021

    • Table Global Anti-Obesity Prescription Drugs Market Sales by Types (Historical)

    • Table Global Anti-Obesity Prescription Drugs Market Sales Market Share by Types (Historical)

    • Figure Global Sales and Growth Rate of Orlistat 2016-2021

    • Figure Global Sales and Growth Rate of Phentermine and Topiramate 2016-2021

    • Figure Global Sales and Growth Rate of Bupropion and Naltrexone 2016-2021

    • Figure Global Sales and Growth Rate of Lorcaserin 2016-2021

    • Figure Global Sales and Growth Rate of Liraglutide 2016-2021

    • Table Global Anti-Obesity Prescription Drugs Market Revenue by Types (Forecast)

    • Table Global Anti-Obesity Prescription Drugs Market Revenue Market Share by Types (Forecast)

    • Table Global Anti-Obesity Prescription Drugs Market Sales by Types (Forecast)

    • Table Global Anti-Obesity Prescription Drugs Market Sales Market Share by Types (Forecast)

    • Figure Global Anti-Obesity Prescription Drugs Market Price By Type from 2016 to 2026

    • Table Downstream Industry Demand Analysis for Anti-Obesity Prescription Drugs

    • Table Global Anti-Obesity Prescription Drugs Market Revenue by Application (Historical)

    • Table Global Anti-Obesity Prescription Drugs Market Revenue Market Share by Application (Historical)

    • Figure Global Revenue and Growth Rate of Pediatric 2016-2021

    • Figure Global Revenue and Growth Rate of Adult 2016-2021

    • Table Global Anti-Obesity Prescription Drugs Market Sales by Application (Historical)

    • Table Global Anti-Obesity Prescription Drugs Market Sales Market Share by Application (Historical)

    • Figure Global Sales and Growth Rate of Pediatric 2016-2021

    • Figure Global Sales and Growth Rate of Adult 2016-2021

    • Table Global Anti-Obesity Prescription Drugs Market Revenue by Application (Forecast)

    • Table Global Anti-Obesity Prescription Drugs Market Revenue Market Share by Application (Forecast)

    • Table Global Anti-Obesity Prescription Drugs Market Sales by Application (Forecast)

    • Table Global Anti-Obesity Prescription Drugs Market Sales Market Share by Application (Forecast)

    • Table Global Anti-Obesity Prescription Drugs Market Revenue by Geography (Historical)

    • Table Global Anti-Obesity Prescription Drugs Market Revenue Market Share by Geography (Historical)

    • Figure Global Anti-Obesity Prescription Drugs Revenue Market Share by Geography in 2020

    • Table Global Anti-Obesity Prescription Drugs Market Sales by Geography (Historical)

    • Table Global Anti-Obesity Prescription Drugs Market Sales Market Share by Geography (Historical)

    • Figure Global Anti-Obesity Prescription Drugs Sales Market Share by Geography in 2020

    • Table Global Anti-Obesity Prescription Drugs Market Revenue by Geography (Forecast)

    • Table Global Anti-Obesity Prescription Drugs Market Revenue Market Share by Geography (Forecast)

    • Table Global Anti-Obesity Prescription Drugs Market Sales by Geography (Forecast)

    • Table Global Anti-Obesity Prescription Drugs Market Sales Market Share by Geography (Forecast)

    • Figure Top Sales Country Geographical Advantage Analysis

    • Table North America Anti-Obesity Prescription Drugs Revenue by Countries from 2016 to 2026

    • Table North America Anti-Obesity Prescription Drugs Revenue Market Share by Countries from 2016 to 2026

    • Figure North America Anti-Obesity Prescription Drugs Revenue Market Share by Major Countries in 2020

    • Table North America Anti-Obesity Prescription Drugs Sales by Countries from 2016 to 2026

    • Table North America Anti-Obesity Prescription Drugs Sales Market Share by Countries from 2016 to 2026

    • Figure North America Anti-Obesity Prescription Drugs Sales Market Share by Major Countries in 2020

    • Figure USA Anti-Obesity Prescription Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure USA Anti-Obesity Prescription Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Canada Anti-Obesity Prescription Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Canada Anti-Obesity Prescription Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Mexico Anti-Obesity Prescription Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Mexico Anti-Obesity Prescription Drugs Market Volume and Growth Rate from 2016 to 2026

    • Table North America Anti-Obesity Prescription Drugs Sales by Types from 2016 to 2026

    • Table North America Anti-Obesity Prescription Drugs Sales Market Share by Types from 2016 to 2026

    • Table North America Anti-Obesity Prescription Drugs Value by Types from 2016 to 2026

    • Table North America Anti-Obesity Prescription Drugs Value Market Share by Types from 2016 to 2026

    • Table North America Anti-Obesity Prescription Drugs Sales by Application from 2016 to 2026

    • Table North America Anti-Obesity Prescription Drugs Sales Market Share by Application from 2016 to 2026

    • Table North America Anti-Obesity Prescription Drugs Value by Application from 2016 to 2026

    • Table North America Anti-Obesity Prescription Drugs Value Market Share by Application from 2016 to 2026

    • Table Europe Anti-Obesity Prescription Drugs Revenue by Countries from 2016 to 2026

    • Table Europe Anti-Obesity Prescription Drugs Revenue Market Share by Countries from 2016 to 2026

    • Figure Europe Anti-Obesity Prescription Drugs Revenue Market Share by Major Countries in 2020

    • Table Europe Anti-Obesity Prescription Drugs Sales by Countries from 2016 to 2026

    • Table Europe Anti-Obesity Prescription Drugs Sales Market Share by Countries from 2016 to 2026

    • Figure Europe Anti-Obesity Prescription Drugs Sales Market Share by Major Countries in 2020

    • Figure Germany Anti-Obesity Prescription Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Germany Anti-Obesity Prescription Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure United Kingdom Anti-Obesity Prescription Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure United Kingdom Anti-Obesity Prescription Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure France Anti-Obesity Prescription Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure France Anti-Obesity Prescription Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Italy Anti-Obesity Prescription Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Italy Anti-Obesity Prescription Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Russia Anti-Obesity Prescription Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Russia Anti-Obesity Prescription Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Spain Anti-Obesity Prescription Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Spain Anti-Obesity Prescription Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Netherlands Anti-Obesity Prescription Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Netherlands Anti-Obesity Prescription Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Switzerland Anti-Obesity Prescription Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Switzerland Anti-Obesity Prescription Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Turkey Anti-Obesity Prescription Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Turkey Anti-Obesity Prescription Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Poland Anti-Obesity Prescription Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Poland Anti-Obesity Prescription Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Sweden Anti-Obesity Prescription Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Sweden Anti-Obesity Prescription Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Belgium Anti-Obesity Prescription Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Belgium Anti-Obesity Prescription Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Austria Anti-Obesity Prescription Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Austria Anti-Obesity Prescription Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Anti-Obesity Prescription Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Others Anti-Obesity Prescription Drugs Market Volume and Growth Rate from 2016 to 2026

    • Table Europe Anti-Obesity Prescription Drugs Sales by Types from 2016 to 2026

    • Table Europe Anti-Obesity Prescription Drugs Sales Market Share by Types from 2016 to 2026

    • Table Europe Anti-Obesity Prescription Drugs Value by Types from 2016 to 2026

    • Table Europe Anti-Obesity Prescription Drugs Value Market Share by Types from 2016 to 2026

    • Table Europe Anti-Obesity Prescription Drugs Sales by Application from 2016 to 2026

    • Table Europe Anti-Obesity Prescription Drugs Sales Market Share by Application from 2016 to 2026

    • Table Europe Anti-Obesity Prescription Drugs Value by Application from 2016 to 2026

    • Table Europe Anti-Obesity Prescription Drugs Value Market Share by Application from 2016 to 2026

    • Table Asia Anti-Obesity Prescription Drugs Revenue by Countries from 2016 to 2026

    • Table Asia Anti-Obesity Prescription Drugs Revenue Market Share by Countries from 2016 to 2026

    • Figure Asia Anti-Obesity Prescription Drugs Revenue Market Share by Major Countries in 2020

    • Table Asia Anti-Obesity Prescription Drugs Sales by Countries from 2016 to 2026

    • Table Asia Anti-Obesity Prescription Drugs Sales Market Share by Countries from 2016 to 2026

    • Figure Asia Anti-Obesity Prescription Drugs Sales Market Share by Major Countries in 2020

    • Figure China Anti-Obesity Prescription Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure China Anti-Obesity Prescription Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Japan Anti-Obesity Prescription Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Japan Anti-Obesity Prescription Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure India Anti-Obesity Prescription Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure India Anti-Obesity Prescription Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure South Korea Anti-Obesity Prescription Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure South Korea Anti-Obesity Prescription Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Malaysia Anti-Obesity Prescription Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Malaysia Anti-Obesity Prescription Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Vietnam Anti-Obesity Prescription Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Vietnam Anti-Obesity Prescription Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Philippines Anti-Obesity Prescription Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Philippines Anti-Obesity Prescription Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Singapore Anti-Obesity Prescription Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Singapore Anti-Obesity Prescription Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Thailand Anti-Obesity Prescription Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Thailand Anti-Obesity Prescription Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Anti-Obesity Prescription Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Others Anti-Obesity Prescription Drugs Market Volume and Growth Rate from 2016 to 2026

    • Table Asia Anti-Obesity Prescription Drugs Sales by Types from 2016 to 2026

    • Table Asia Anti-Obesity Prescription Drugs Sales Market Share by Types from 2016 to 2026

    • Table Asia Anti-Obesity Prescription Drugs Value by Types from 2016 to 2026

    • Table Asia Anti-Obesity Prescription Drugs Value Market Share by Types from 2016 to 2026

    • Table Asia Anti-Obesity Prescription Drugs Sales by Application from 2016 to 2026

    • Table Asia Anti-Obesity Prescription Drugs Sales Market Share by Application from 2016 to 2026

    • Table Asia Anti-Obesity Prescription Drugs Value by Application from 2016 to 2026

    • Table Asia Anti-Obesity Prescription Drugs Value Market Share by Application from 2016 to 2026

    • Table South America Anti-Obesity Prescription Drugs Revenue by Countries from 2016 to 2026

    • Table South America Anti-Obesity Prescription Drugs Revenue Market Share by Countries from 2016 to 2026

    • Figure South America Anti-Obesity Prescription Drugs Revenue Market Share by Major Countries in 2020

    • Table South America Anti-Obesity Prescription Drugs Sales by Countries from 2016 to 2026

    • Table South America Anti-Obesity Prescription Drugs Sales Market Share by Countries from 2016 to 2026

    • Figure South America Anti-Obesity Prescription Drugs Sales Market Share by Major Countries in 2020

    • Figure Brazil Anti-Obesity Prescription Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Brazil Anti-Obesity Prescription Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Argentina Anti-Obesity Prescription Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Argentina Anti-Obesity Prescription Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Colombia Anti-Obesity Prescription Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Colombia Anti-Obesity Prescription Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Chile Anti-Obesity Prescription Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Chile Anti-Obesity Prescription Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Anti-Obesity Prescription Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Others Anti-Obesity Prescription Drugs Market Volume and Growth Rate from 2016 to 2026

    • Table South America Anti-Obesity Prescription Drugs Sales by Types from 2016 to 2026

    • Table South America Anti-Obesity Prescription Drugs Sales Market Share by Types from 2016 to 2026

    • Table South America Anti-Obesity Prescription Drugs Value by Types from 2016 to 2026

    • Table South America Anti-Obesity Prescription Drugs Value Market Share by Types from 2016 to 2026

    • Table South America Anti-Obesity Prescription Drugs Sales by Application from 2016 to 2026

    • Table South America Anti-Obesity Prescription Drugs Sales Market Share by Application from 2016 to 2026

    • Table South America Anti-Obesity Prescription Drugs Value by Application from 2016 to 2026

    • Table South America Anti-Obesity Prescription Drugs Value Market Share by Application from 2016 to 2026

    • Table Middle East Anti-Obesity Prescription Drugs Revenue by Countries from 2016 to 2026

    • Table Middle East Anti-Obesity Prescription Drugs Revenue Market Share by Countries from 2016 to 2026

    • Figure Middle East Anti-Obesity Prescription Drugs Revenue Market Share by Major Countries in 2020

    • Table Middle East Anti-Obesity Prescription Drugs Sales by Countries from 2016 to 2026

    • Table Middle East Anti-Obesity Prescription Drugs Sales Market Share by Countries from 2016 to 2026

    • Figure Middle East Anti-Obesity Prescription Drugs Sales Market Share by Major Countries in 2020

    • Figure United Arab Emirates (UAE) Anti-Obesity Prescription Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure United Arab Emirates (UAE) Anti-Obesity Prescription Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Saudi Arabia Anti-Obesity Prescription Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Saudi Arabia Anti-Obesity Prescription Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Anti-Obesity Prescription Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Others Anti-Obesity Prescription Drugs Market Volume and Growth Rate from 2016 to 2026

    • Table Middle East Anti-Obesity Prescription Drugs Sales by Types from 2016 to 2026

    • Table Middle East Anti-Obesity Prescription Drugs Sales Market Share by Types from 2016 to 2026

    • Table Middle East Anti-Obesity Prescription Drugs Value by Types from 2016 to 2026

    • Table Middle East Anti-Obesity Prescription Drugs Value Market Share by Types from 2016 to 2026

    • Table Middle East Anti-Obesity Prescription Drugs Sales by Application from 2016 to 2026

    • Table Middle East Anti-Obesity Prescription Drugs Sales Market Share by Application from 2016 to 2026

    • Table Middle East Anti-Obesity Prescription Drugs Value by Application from 2016 to 2026

    • Table Middle East Anti-Obesity Prescription Drugs Value Market Share by Application from 2016 to 2026

    • Table Africa Anti-Obesity Prescription Drugs Revenue by Countries from 2016 to 2026

    • Table Africa Anti-Obesity Prescription Drugs Revenue Market Share by Countries from 2016 to 2026

    • Figure Africa Anti-Obesity Prescription Drugs Revenue Market Share by Major Countries in 2020

    • Table Africa Anti-Obesity Prescription Drugs Sales by Countries from 2016 to 2026

    • Table Africa Anti-Obesity Prescription Drugs Sales Market Share by Countries from 2016 to 2026

      • Figure Africa Anti-Obesity Prescription Drugs Sales Market Share by Major Countries in 2020

    • Figure Nigeria Anti-Obesity Prescription Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Nigeria Anti-Obesity Prescription Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Egypt Anti-Obesity Prescription Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Egypt Anti-Obesity Prescription Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure South Africa Anti-Obesity Prescription Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure South Africa Anti-Obesity Prescription Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Anti-Obesity Prescription Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Others Anti-Obesity Prescription Drugs Market Volume and Growth Rate from 2016 to 2026

    • Table Africa Anti-Obesity Prescription Drugs Sales by Types from 2016 to 2026

    • Table Africa Anti-Obesity Prescription Drugs Sales Market Share by Types from 2016 to 2026

    • Table Africa Anti-Obesity Prescription Drugs Value by Types from 2016 to 2026

    • Table Africa Anti-Obesity Prescription Drugs Value Market Share by Types from 2016 to 2026

    • Table Africa Anti-Obesity Prescription Drugs Sales by Application from 2016 to 2026

    • Table Africa Anti-Obesity Prescription Drugs Sales Market Share by Application from 2016 to 2026

    • Table Africa Anti-Obesity Prescription Drugs Value by Application from 2016 to 2026

    • Table Africa Anti-Obesity Prescription Drugs Value Market Share by Application from 2016 to 2026

    • Table Oceania Anti-Obesity Prescription Drugs Revenue by Countries from 2016 to 2026

    • Table Oceania Anti-Obesity Prescription Drugs Revenue Market Share by Countries from 2016 to 2026

    • Figure Oceania Anti-Obesity Prescription Drugs Revenue Market Share by Major Countries in 2020

    • Table Oceania Anti-Obesity Prescription Drugs Sales by Countries from 2016 to 2026

    • Table Oceania Anti-Obesity Prescription Drugs Sales Market Share by Countries from 2016 to 2026

    • Figure Oceania Anti-Obesity Prescription Drugs Sales Market Share by Major Countries in 2020

    • Figure Australia Anti-Obesity Prescription Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Australia Anti-Obesity Prescription Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure New Zealand Anti-Obesity Prescription Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure New Zealand Anti-Obesity Prescription Drugs Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Anti-Obesity Prescription Drugs Market Value and Growth Rate from 2016 to 2026

    • Figure Others Anti-Obesity Prescription Drugs Market Volume and Growth Rate from 2016 to 2026

    • Table Oceania Anti-Obesity Prescription Drugs Sales by Types from 2016 to 2026

    • Table Oceania Anti-Obesity Prescription Drugs Sales Market Share by Types from 2016 to 2026

    • Table Oceania Anti-Obesity Prescription Drugs Value by Types from 2016 to 2026

    • Table Oceania Anti-Obesity Prescription Drugs Value Market Share by Types from 2016 to 2026

    • Table Oceania Anti-Obesity Prescription Drugs Sales by Application from 2016 to 2026

    • Table Oceania Anti-Obesity Prescription Drugs Sales Market Share by Application from 2016 to 2026

    • Table Oceania Anti-Obesity Prescription Drugs Value by Application from 2016 to 2026

    • Table Oceania Anti-Obesity Prescription Drugs Value Market Share by Application from 2016 to 2026

    • Table Production Base and Market Concentration Rate of Raw Material

    • Figure Key Raw Materials Price Trend

    • Figure Manufacturing Process Analysis of Anti-Obesity Prescription Drugs

    • Figure Top 10 Market Share in 2020

    • Table Major Downstream Buyers of Anti-Obesity Prescription Drugs with Contact Information


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US